6550--Diasorin Virology Testing Reagents and Supplies

SOL #: 36C24126Q0316Special NoticeSole Source

Overview

Buyer

Veterans Affairs
Veterans Affairs, Department Of
241-NETWORK CONTRACT OFFICE 01 (36C241)
TOGUS, ME, 04330, United States

Place of Performance

Place of performance not available

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

PSC

In Vitro Diagnostic Substances, Reagents, Test Kits And Sets (6550)

Set Aside

No set aside specified

Timeline

1
Posted
Mar 12, 2026
2
Action Date
Mar 20, 2026, 7:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The Department of Veterans Affairs (VA), specifically the Network Consolidated Laboratory (NCL) of VISN 1 New England, has issued a Special Notice of intent to solicit a sole source Blanket Purchase Agreement (BPA) for Diasorin Molecular LLC virology testing reagents and supplies. These products are required for VA-owned equipment. While the intent is sole source, other responsible sources are invited to submit information for market research. Responses are due March 20, 2026, by 3:00 PM EST.

Scope of Work

The requirement is for a 5-year Blanket Purchase Agreement (BPA) for molecular biology/virology testing reagents and supplies. These items must be manufactured and distributed solely by Diasorin Molecular LLC, as they are specific to existing VA-owned and validated equipment. The supplies are for virology diagnostic testing and must comply with the VHA 1106 Directive for Pathology and Laboratory Medicine Services.

Contract & Timeline

  • Contract Type: Blanket Purchase Agreement (BPA)
  • Period of Performance: 5 years, from May 1, 2026, to April 30, 2031.
    • Year 1: 05/01/2026 – 04/30/2027
    • Year 2: 05/01/2027 – 04/30/2028
    • Year 3: 05/01/2028 – 04/30/2029
    • Year 4: 05/01/2029 – 04/30/2030
    • Year 5: 05/01/2030 – 04/30/2031
  • Authority: Simplified Procedures for Certain Commercial Products and Commercial Services under FAR 13.5, citing 10 U.S.C. 3205-3208 and 41 U.S.C. 3305.
  • Response Due: March 20, 2026, by 3:00 PM EST.
  • Published Date: March 12, 2026.

Submission & Evaluation

This is not a request for competitive proposals, and no solicitation will be posted. Requests for a solicitation will not receive a response. However, responsible sources who believe they are qualified to provide these specific Diasorin products may submit detailed and relevant documentation to Sarah.Otis@va.gov. This information will be used for market research to determine if a competitive procurement is feasible, though the decision to compete remains solely at the government's discretion.

Additional Notes

  • NAICS Code: 325413 (In Vitro Diagnostic Substances, Reagents, Test Kits And Sets)
  • Point of Contact: Sarah Otis, Contract Specialist, Sarah.Otis@va.gov, 774-826-4929.

People

Points of Contact

Sarah OtisContract SpecialistPRIMARY

Files

Files

Download

Versions

Version 1Viewing
Special Notice
Posted: Mar 12, 2026
6550--Diasorin Virology Testing Reagents and Supplies | GovScope